ES2120440T3 - Composiciones dieteticas o farmaceuticas que comprenden bacterias lacticas liofilizadas. - Google Patents

Composiciones dieteticas o farmaceuticas que comprenden bacterias lacticas liofilizadas.

Info

Publication number
ES2120440T3
ES2120440T3 ES92830653T ES92830653T ES2120440T3 ES 2120440 T3 ES2120440 T3 ES 2120440T3 ES 92830653 T ES92830653 T ES 92830653T ES 92830653 T ES92830653 T ES 92830653T ES 2120440 T3 ES2120440 T3 ES 2120440T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
diseases
laughter
people
dietetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92830653T
Other languages
English (en)
Inventor
Vesely Renata Maria Cavaliere
Simone Claudio De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2120440T3 publication Critical patent/ES2120440T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/249—Thermophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LAS COMPOSICIONES FARMACEUTICAS CON BACTERIAS LACTEAS LIOFILIZADAS DE ALTA CONCENTRACION COMBINADAS CON EXCIPIENTES FARMACOLOCIGAMENTE ACEPTABLES Y, DE FORMA DISCRECIONAL, CON DROGAS APROPIADAS Y FISIOLOGICAMENTE COMPATIBLES SON IDONEAS PARA RECUPERAR LA MEMBRANA MUCOSA DEL INTESTINO Y PARA MODULAR LA CINETICA DE LAS CELULAS EPITELIAS Y EL POTENCIAL DE LAS ENZIMAS DEL INTESTINO, CUANDO HAYAN SIDOS ALTERADOS A CAUSA DE ESTRES, GASTROENTERITIS, COLITIS, CONSTIPACION O DIARREA. ADICIONALMENTE SIRVEN PARA RECOLONIZAR EL INTESTION TRAS TRASTORNOS NUTRITIVOS, INTERVENCIONES QUIRURGICAS, QUIMOTERAPIA O ENFERMEDADES CONTAGIOSAS, HEPATOPATIAS A CAUSA DE INTOXICACION, METABOLOPATIA O INFECCION COMO ADYUVANTES PARA CONTROLAR HIPERAMONIEMIA Y ENDOTOXEMIA MIENTRAS LA INSUFICIENCIA HEPATICA ESTE EN PROGRESO, EN CASO DE FALTA DE INMUNIDAD HUMORAL Y DE INMUNIDAD MUCOSAL Y SISTEMICA MEDIATA POR CELULAS ACOMPAÑADAS DE ENFERMEDADES SECUNDARIAS A LA DEFICIENCIA INMUNOLOGICA, PARA HIPERLIPOPROTEINEMIA Y HIPERCOLESTEREMIA, Y COMO ADYUVANTES EN TERAPIAS DE DIABETES.
ES92830653T 1992-02-10 1992-12-04 Composiciones dieteticas o farmaceuticas que comprenden bacterias lacticas liofilizadas. Expired - Lifetime ES2120440T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI920256A IT1254210B (it) 1992-02-10 1992-02-10 Composizioni dietetiche e/o farmaceutiche a base di batteri lattici liofilizzati, loro preparazione e impiego

Publications (1)

Publication Number Publication Date
ES2120440T3 true ES2120440T3 (es) 1998-11-01

Family

ID=11361865

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92830653T Expired - Lifetime ES2120440T3 (es) 1992-02-10 1992-12-04 Composiciones dieteticas o farmaceuticas que comprenden bacterias lacticas liofilizadas.

Country Status (6)

Country Link
EP (1) EP0555618B1 (es)
JP (1) JPH0656680A (es)
DE (1) DE69226622T2 (es)
DK (1) DK0555618T3 (es)
ES (1) ES2120440T3 (es)
IT (1) IT1254210B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9318439D0 (en) * 1993-09-06 1993-10-20 Zeneca Ltd Probiotics
AT405235B (de) * 1995-11-02 1999-06-25 Helmut Dr Viernstein Probiotisch wirksame formulierung
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
AUPN907296A0 (en) * 1996-04-02 1996-04-26 Commonwealth Scientific And Industrial Research Organisation Biocontrol agents for use in treatment of opportunistic infections
IT1288119B1 (it) * 1996-06-28 1998-09-10 Renata Maria Anna Ve Cavaliere Composizioni dietetiche da utilizzare nell'alimentazione per via enterica
DE19637112C2 (de) * 1996-09-12 1999-11-18 Matthias Kleespies Verfahren zur Herstellung fester Körper und Verwendung derartiger Körper
DE69600525T2 (de) * 1996-12-23 1998-12-10 Sitia Yomo Spa Lyophilisierte, lebende Bakerien enthaltende Nahrungszusammensetzung
RO112995B1 (ro) * 1997-08-05 1998-03-30 Rodica Teodorescu Produs medicamentos pentru terapia colonului
CN1119154C (zh) * 1998-01-20 2003-08-27 上海信谊药业有限公司 双歧三联活菌制剂及制备方法
EP1020123A1 (en) * 1999-01-18 2000-07-19 Sitia-Yomo S.p.A. Beverages containing live lactic bacteria
IT1306716B1 (it) 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
WO2002002138A1 (en) * 2000-07-03 2002-01-10 Probendo Pty Ltd Treating endotoxemia and related disorders with probiotics
EA006397B1 (ru) * 2001-02-06 2005-12-29 Сосьете Де Продюи Нестле С.А. Связывающие эндотоксин штаммы лактобактерий и бифидобактерий, обладающие гидрофобными свойствами, и способы их применения
WO2003018051A1 (en) * 2001-08-27 2003-03-06 Vic Jira Anti-fungal composition
SE526711C2 (sv) 2003-01-31 2005-10-25 Probi Ab Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav
JP2004262773A (ja) * 2003-02-17 2004-09-24 Ryoshoku Kenkyukai 免疫機能改善を目的としたビフィズス菌製剤
ITRM20040505A1 (it) * 2004-10-15 2005-01-15 Cd Invest Liofilizzati di batteri lattici e bifidobatteri ad alta dispersibilita'.
JP5413819B2 (ja) * 2008-02-08 2014-02-12 国立大学法人広島大学 肝機能改善剤およびその製造用ツール、ならびにこれらの利用
FR2930443B1 (fr) 2008-04-29 2010-06-25 Oreal Produit extemporane de soin a base d'un lyophilisat de microorganisme et de tensioactif(s) de hlb superieur ou egal a 12
JP2009102324A (ja) * 2008-11-27 2009-05-14 Morishita Jintan Kk 乳酸菌含有血中アンモニア低減剤
ITMO20090067A1 (it) * 2009-03-23 2010-09-24 Ct Sperimentale Del Latte S P A Composizione a base di microrganismi utilizzabile per preparare un prodotto alimentare
EP2533803B1 (en) 2010-02-11 2016-01-20 Technische Universität München Lactocepins for use in the treatment of ip-10-mediated inflammatory diseases
JP6020981B2 (ja) * 2010-10-15 2016-11-02 国立研究開発法人農業・食品産業技術総合研究機構 カテコールアミン認識性を指標に選抜した微生物とカテコールアミン含有組成物
JP6632802B2 (ja) 2012-01-16 2020-01-22 マッケンナ，エリザベス 肝疾患及び肝障害を治療するための組成物及び方法
EP2898073A4 (en) 2012-09-21 2016-03-23 Elizabeth Mckenna Naturally-occurring CPG-oligonucleotide compositions and therapeutic applications thereof
JP6051353B2 (ja) * 2015-03-09 2016-12-27 株式会社東洋新薬 血中コレステロール上昇抑制剤
US11606965B2 (en) 2016-05-11 2023-03-21 Chr. Hansen A/S Lactic acid bacteria for a heat-treated food product for storage at ambient temperature
KR102009731B1 (ko) 2019-04-15 2019-08-12 주식회사 쎌바이오텍 단백질 가수분해물을 이용한 단백질-다당류 이중코팅 유산균의 제조방법
WO2021048350A1 (en) 2019-09-12 2021-03-18 Chr. Hansen A/S Lactic acid bacteria for a heat-treated food product for storage at ambient temperature

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60149527A (ja) * 1984-01-17 1985-08-07 Seikenkai 生体内脱臭剤
JPH0696538B2 (ja) * 1985-12-19 1994-11-30 株式会社アドバンス 抗発癌剤
JPH0774158B2 (ja) * 1986-09-03 1995-08-09 東亜薬品工業株式会社 ３種菌共生混合物
US5143845A (en) * 1986-09-03 1992-09-01 Toa Pharmaceutical Co., Ltd. Mixture of saccarifying lactic acid producing and butyric acid producing bacteria
JPS6391076A (ja) * 1986-10-06 1988-04-21 Toa Yakuhin Kogyo Kk ３種菌の培養法
EP0291578A1 (en) * 1987-05-20 1988-11-23 Kopalnia Soli "Wieliczka" Table salt enriched in bioelements
JP2612001B2 (ja) * 1987-09-04 1997-05-21 フロイント産業株式会社 腸内有用細菌含有顆粒およびその製造方法
US4806368A (en) * 1987-09-16 1989-02-21 Reddy Malireddy S Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation

Also Published As

Publication number Publication date
DE69226622T2 (de) 1999-02-11
DK0555618T3 (da) 1999-05-17
ITMI920256A1 (it) 1993-08-10
DE69226622D1 (de) 1998-09-17
EP0555618A2 (en) 1993-08-18
JPH0656680A (ja) 1994-03-01
IT1254210B (it) 1995-09-14
EP0555618A3 (en) 1994-06-22
EP0555618B1 (en) 1998-08-12
ITMI920256A0 (it) 1992-02-10

Similar Documents

Publication Publication Date Title
ES2120440T3 (es) Composiciones dieteticas o farmaceuticas que comprenden bacterias lacticas liofilizadas.
ES2232869T3 (es) Tratamiento contra la diarrea.
Alverdy et al. Effect of commercially available chemically defined liquid diets on the intestinal microflora and bacterial translocation from the gut
Chandler et al. Bromelain protects piglets from diarrhoea caused by oral challenge with K88 positive enterotoxigenicEscherichia coli
US8735087B2 (en) Use of alkaline phosphatase for preventing or reducing liver disease
US5494664A (en) Bifidobacteria
Ricour et al. Home parenteral nutrition in children: 8 years of experience with 112 patients
TWI494114B (zh) 鼠李醣乳酸桿菌gg(lgg)於治療、預防或減輕全身性發炎之用途
ES2293419T3 (es) Bifidobacterias y preparaciones que las contienen.
US20100135971A1 (en) Probiotics in a pre- and/or post surgical environment
US20070148147A1 (en) Bacterial composition and its use
Rambaud et al. Gut microflora: digestive physiology and pathology
ES2760256T3 (es) Composición
ITFI990051A1 (it) Composizione farmaceutica a base di fermenti lattici e carboidratinon assorbibili contenente un sale di calcio ed un sale di alluminio
CN101146525A (zh) 与长链多不饱和脂肪酸组合的鼠李糖乳杆菌用于治疗、预防或减少配方喂养婴儿的全身性炎症的用途
CN110638043A (zh) 一种富含益生菌的全营养配方食品及其制备方法与应用
ES2276793T3 (es) Empleo de la bacteria del acido lactico para la prevencion de la peritonitis.
CA2531261A1 (en) Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
CN101849969A (zh) 产酪酸有益菌在制备防治重症疾病肠道屏障损伤及损伤后并发症制剂中的应用
JPH07126177A (ja) 潰瘍性大腸炎治療剤
JPH05506228A (ja) 止痢薬組成物及び方法
CN113186118B (zh) 一种用于提高母猪生产性能的复合益生菌制剂及其制备方法
Hilton et al. Diffuse progressive interstitial fibrosis of the lungs in childhood (Hamman-Rich syndrome)
Gourine et al. Symbiotic enhances gut mucosa recovery rate and reduces overgrowth of bacteria in experimental protein malnutrition
RU2123345C1 (ru) Средство для лечения дисбактериоза

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 555618

Country of ref document: ES